| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 6.24e-06 | 132 | 71 | 6 | GO:0000956 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 4.18e-05 | 373 | 71 | 8 | GO:0006402 | |
| GeneOntologyBiologicalProcess | positive regulation of collagen fibril organization | 6.98e-05 | 4 | 71 | 2 | GO:1904028 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 7.45e-05 | 65 | 71 | 4 | GO:0000288 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 9.26e-05 | 309 | 71 | 7 | GO:0061013 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 1.16e-04 | 432 | 71 | 8 | GO:0006401 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.38e-04 | 443 | 71 | 8 | GO:1903311 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.90e-04 | 464 | 71 | 8 | GO:0141188 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 2.31e-04 | 87 | 71 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 2.68e-04 | 259 | 71 | 6 | GO:1903313 | |
| GeneOntologyBiologicalProcess | regulation of translation | 2.90e-04 | 494 | 71 | 8 | GO:0006417 | |
| GeneOntologyCellularComponent | CRD-mediated mRNA stability complex | 1.79e-04 | 6 | 73 | 2 | GO:0070937 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 3.55e-04 | 269 | 73 | 6 | GO:0036464 | |
| GeneOntologyCellularComponent | P-body | 4.49e-04 | 102 | 73 | 4 | GO:0000932 | |
| GeneOntologyCellularComponent | external encapsulating structure | 4.62e-04 | 658 | 73 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 5.01e-04 | 287 | 73 | 6 | GO:0035770 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 5.98e-04 | 110 | 73 | 4 | GO:0120111 | |
| GeneOntologyCellularComponent | dendrite | ERBB4 YBX1 LAMA2 GRIA2 APLP2 KIF3C GRM3 CAPRIN1 HNRNPU SAMD4A | 7.68e-04 | 858 | 73 | 10 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ERBB4 YBX1 LAMA2 GRIA2 APLP2 KIF3C GRM3 CAPRIN1 HNRNPU SAMD4A | 7.82e-04 | 860 | 73 | 10 | GO:0097447 |
| GeneOntologyCellularComponent | basement membrane | 8.81e-04 | 122 | 73 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | microfibril | 9.15e-04 | 13 | 73 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.58e-03 | 17 | 73 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.01e-03 | 656 | 73 | 8 | GO:0031012 | |
| Domain | Pectin_lyase_fold/virulence | 3.16e-06 | 8 | 73 | 3 | IPR011050 | |
| Domain | EGF-like_dom | 5.68e-06 | 249 | 73 | 8 | IPR000742 | |
| Domain | EGF_1 | 6.76e-06 | 255 | 73 | 8 | PS00022 | |
| Domain | EGF-like_CS | 8.01e-06 | 261 | 73 | 8 | IPR013032 | |
| Domain | EGF_2 | 8.95e-06 | 265 | 73 | 8 | PS01186 | |
| Domain | EGF_3 | 3.67e-05 | 235 | 73 | 7 | PS50026 | |
| Domain | G8 | 9.00e-05 | 4 | 73 | 2 | PF10162 | |
| Domain | G8_domain | 9.00e-05 | 4 | 73 | 2 | IPR019316 | |
| Domain | G8 | 9.00e-05 | 4 | 73 | 2 | PS51484 | |
| Domain | G8 | 9.00e-05 | 4 | 73 | 2 | SM01225 | |
| Domain | COLD_SHOCK | 2.24e-04 | 6 | 73 | 2 | PS00352 | |
| Domain | PbH1 | 2.24e-04 | 6 | 73 | 2 | SM00710 | |
| Domain | Cold-shock_CS | 2.24e-04 | 6 | 73 | 2 | IPR019844 | |
| Domain | PbH1 | 2.24e-04 | 6 | 73 | 2 | IPR006626 | |
| Domain | EGF | 3.14e-04 | 235 | 73 | 6 | SM00181 | |
| Domain | Growth_fac_rcpt_ | 3.62e-04 | 156 | 73 | 5 | IPR009030 | |
| Domain | CSP | 4.16e-04 | 8 | 73 | 2 | SM00357 | |
| Domain | Cold_shock_prot | 4.16e-04 | 8 | 73 | 2 | IPR011129 | |
| Domain | CSD | 4.16e-04 | 8 | 73 | 2 | PF00313 | |
| Domain | CSP_DNA-bd | 4.16e-04 | 8 | 73 | 2 | IPR002059 | |
| Domain | ASX_HYDROXYL | 6.34e-04 | 100 | 73 | 4 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.90e-04 | 106 | 73 | 4 | IPR000152 | |
| Domain | MBOAT_fam | 8.10e-04 | 11 | 73 | 2 | IPR004299 | |
| Domain | MBOAT | 8.10e-04 | 11 | 73 | 2 | PF03062 | |
| Domain | UBX | 9.70e-04 | 12 | 73 | 2 | SM00166 | |
| Domain | UBX | 1.14e-03 | 13 | 73 | 2 | PF00789 | |
| Domain | UBX | 1.14e-03 | 13 | 73 | 2 | PS50033 | |
| Domain | UBX_dom | 1.14e-03 | 13 | 73 | 2 | IPR001012 | |
| Domain | CCP | 1.23e-03 | 54 | 73 | 3 | SM00032 | |
| Domain | EGF_CA | 1.33e-03 | 122 | 73 | 4 | SM00179 | |
| Domain | SUSHI | 1.37e-03 | 56 | 73 | 3 | PS50923 | |
| Domain | EGF-like_Ca-bd_dom | 1.41e-03 | 124 | 73 | 4 | IPR001881 | |
| Domain | Sushi_SCR_CCP_dom | 1.44e-03 | 57 | 73 | 3 | IPR000436 | |
| Domain | TSP_1 | 1.92e-03 | 63 | 73 | 3 | PF00090 | |
| Domain | TSP1 | 2.10e-03 | 65 | 73 | 3 | SM00209 | |
| Domain | TSP1_rpt | 2.10e-03 | 65 | 73 | 3 | IPR000884 | |
| Domain | TSP1 | 2.10e-03 | 65 | 73 | 3 | PS50092 | |
| Domain | - | 2.21e-03 | 18 | 73 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 2.21e-03 | 18 | 73 | 2 | IPR020901 | |
| Domain | KU | 2.21e-03 | 18 | 73 | 2 | SM00131 | |
| Domain | BPTI_KUNITZ_2 | 2.47e-03 | 19 | 73 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 2.47e-03 | 19 | 73 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 2.47e-03 | 19 | 73 | 2 | PS00280 | |
| Domain | Kunitz_BPTI | 3.61e-03 | 23 | 73 | 2 | IPR002223 | |
| Pubmed | UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. | 2.09e-07 | 62 | 73 | 5 | 18775313 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ZKSCAN1 YBX1 NCBP1 NOL9 API5 FLG2 VIRMA CAPRIN1 HNRNPU VDAC2 | 5.47e-07 | 605 | 73 | 10 | 28977666 |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 1.16e-06 | 256 | 73 | 7 | 32698014 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.22e-06 | 258 | 73 | 7 | 37794589 | |
| Pubmed | 1.45e-06 | 383 | 73 | 8 | 29331416 | ||
| Pubmed | Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. | 1.54e-06 | 40 | 73 | 4 | 23825951 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | IVNS1ABP DOCK4 CRTC3 ERBB4 DST TAB1 PUM1 WDR26 VIRMA NSD3 SAMD4A | 1.77e-06 | 861 | 73 | 11 | 36931259 |
| Pubmed | Quantitative study of the interactome of PKCζ involved in the EGF-induced tumor cell chemotaxis. | 2.56e-06 | 184 | 73 | 6 | 23402259 | |
| Pubmed | DOCK4 ERBB4 UBXN4 NSFL1C CELSR2 YBX1 GRIA2 TAB1 ALDH6A1 WDR26 CAPRIN1 HNRNPU | 4.19e-06 | 1139 | 73 | 12 | 36417873 | |
| Pubmed | Internalization of AMPA-type Glutamate Receptor in the MIN6 Pancreatic β-cell Line. | 4.35e-06 | 2 | 73 | 2 | 32581155 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 31726086 | ||
| Pubmed | Mammalian male and female germ cells express a germ cell-specific Y-Box protein, MSY2. | 4.35e-06 | 2 | 73 | 2 | 9780336 | |
| Pubmed | TSH/TSHR Signaling Suppresses Fatty Acid Synthase (FASN) Expression in Adipocytes. | 4.35e-06 | 2 | 73 | 2 | 25655684 | |
| Pubmed | 4.39e-06 | 202 | 73 | 6 | 29540532 | ||
| Pubmed | FASN A1CF YBX1 PEG3 FBXO11 NCBP1 NOL9 FLG2 VIRMA CAPRIN1 CNN2 NPLOC4 VDAC2 | 5.00e-06 | 1371 | 73 | 13 | 36244648 | |
| Pubmed | 5.51e-06 | 613 | 73 | 9 | 22268729 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 5.76e-06 | 462 | 73 | 8 | 31138677 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 16954378 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 16894240 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 23929941 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 36635270 | ||
| Pubmed | The Role of Diacylglycerol Acyltransferase (DGAT) 1 and 2 in Cardiac Metabolism and Function. | 1.30e-05 | 3 | 73 | 2 | 29563512 | |
| Pubmed | 1.88e-05 | 261 | 73 | 6 | 33277362 | ||
| Pubmed | 2.05e-05 | 551 | 73 | 8 | 34728620 | ||
| Pubmed | 2.33e-05 | 271 | 73 | 6 | 26816005 | ||
| Pubmed | 2.38e-05 | 272 | 73 | 6 | 31010829 | ||
| Pubmed | Elastogenic protein expression of a highly elastic murine spinal ligament: the ligamentum flavum. | 2.60e-05 | 4 | 73 | 2 | 22685574 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 25301953 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 20614234 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 20301293 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 15619115 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 16234241 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 16733060 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 19477188 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | IVNS1ABP FASN DST NSFL1C YBX1 TAB1 NOL9 API5 WDR26 CAPRIN1 HNRNPU | 2.66e-05 | 1149 | 73 | 11 | 35446349 |
| Pubmed | 2.80e-05 | 28 | 73 | 3 | 38492217 | ||
| Pubmed | DST CELSR2 ZKSCAN1 GRIA2 NOL9 GRM3 WDR26 VIRMA CAPRIN1 HNRNPU | 3.24e-05 | 963 | 73 | 10 | 28671696 | |
| Pubmed | 3.56e-05 | 176 | 73 | 5 | 28692057 | ||
| Pubmed | 3.59e-05 | 777 | 73 | 9 | 35844135 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IVNS1ABP FASN YBX1 NCBP1 APLP2 KIF3C NOL9 API5 PUM1 CAPRIN1 HNRNPU VDAC2 | 3.88e-05 | 1425 | 73 | 12 | 30948266 |
| Pubmed | 4.21e-05 | 32 | 73 | 3 | 19542561 | ||
| Pubmed | FASN DST YBX1 DAB2 TRAPPC10 NCBP1 WDR26 CAPRIN1 NPLOC4 HNRNPU VDAC2 SAMD4A | 4.30e-05 | 1440 | 73 | 12 | 30833792 | |
| Pubmed | Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4. | 4.33e-05 | 5 | 73 | 2 | 12411482 | |
| Pubmed | Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. | 4.33e-05 | 5 | 73 | 2 | 19632177 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 27226613 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 17255108 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 10811609 | ||
| Pubmed | Differential regulation of elastic fiber formation by fibulin-4 and -5. | 4.33e-05 | 5 | 73 | 2 | 19570982 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 34048454 | ||
| Pubmed | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. | 5.00e-05 | 189 | 73 | 5 | 29449217 | |
| Pubmed | 5.53e-05 | 35 | 73 | 3 | 22337587 | ||
| Pubmed | 5.87e-05 | 469 | 73 | 7 | 37314180 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FASN DST YBX1 NCBP1 NOL9 FLG2 VIRMA CAPRIN1 HNRNPU NSD3 VDAC2 | 6.00e-05 | 1257 | 73 | 11 | 36526897 |
| Pubmed | 6.03e-05 | 36 | 73 | 3 | 17289661 | ||
| Pubmed | Proteomic and genomic analysis of PITX2 interacting and regulating networks. | 6.48e-05 | 6 | 73 | 2 | 19174163 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 19349279 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 29551912 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 27913212 | ||
| Pubmed | Identification of proteins that interact with BRCA1 by Far-Western library screening. | 6.48e-05 | 6 | 73 | 2 | 11746496 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 21645854 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 6.52e-05 | 477 | 73 | 7 | 31300519 | |
| Pubmed | 6.95e-05 | 655 | 73 | 8 | 35819319 | ||
| Pubmed | FBN1 DST CIAO3 MTIF2 EFEMP2 PEG3 FBXO11 NCBP1 WDR26 CAPRIN1 DSCAML1 | 7.31e-05 | 1285 | 73 | 11 | 35914814 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 8.57e-05 | 1082 | 73 | 10 | 38697112 | |
| Pubmed | 8.61e-05 | 212 | 73 | 5 | 23463506 | ||
| Pubmed | DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage. | 9.06e-05 | 7 | 73 | 2 | 23042607 | |
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 34678304 | ||
| Pubmed | Imbalances in p97 co-factor interactions in human proteinopathy. | 9.06e-05 | 7 | 73 | 2 | 20414249 | |
| Pubmed | 1.00e-04 | 114 | 73 | 4 | 31553912 | ||
| Pubmed | FASN YBX1 PEG3 NCBP1 API5 WDR26 CAPRIN1 CNN2 NPLOC4 HNRNPU VDAC2 | 1.02e-04 | 1335 | 73 | 11 | 29229926 | |
| Pubmed | Mass spectrometry-based proteomics revealed Glypican-1 as a novel ADAM17 substrate. | 1.07e-04 | 116 | 73 | 4 | 27576135 | |
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 1.11e-04 | 224 | 73 | 5 | 28443643 | |
| Pubmed | Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway. | 1.21e-04 | 8 | 73 | 2 | 31201465 | |
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 25078495 | ||
| Pubmed | Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. | 1.21e-04 | 8 | 73 | 2 | 19029303 | |
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 10809782 | ||
| Pubmed | 1.26e-04 | 46 | 73 | 3 | 34265304 | ||
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 1.40e-04 | 375 | 73 | 6 | 32788342 | |
| Pubmed | 1.46e-04 | 378 | 73 | 6 | 34315543 | ||
| Pubmed | 1.51e-04 | 239 | 73 | 5 | 26641092 | ||
| Pubmed | Distribution of protocadherin 9 protein in the developing mouse nervous system. | 1.55e-04 | 9 | 73 | 2 | 22982106 | |
| Pubmed | Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specific manner. | 1.55e-04 | 9 | 73 | 2 | 34739333 | |
| Pubmed | 1.55e-04 | 9 | 73 | 2 | 8871564 | ||
| Pubmed | Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. | 1.55e-04 | 9 | 73 | 2 | 11247302 | |
| Pubmed | 1.69e-04 | 245 | 73 | 5 | 35652658 | ||
| Pubmed | 1.72e-04 | 51 | 73 | 3 | 26839216 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 1.72e-04 | 558 | 73 | 7 | 27591049 | |
| Pubmed | 1.82e-04 | 52 | 73 | 3 | 26265008 | ||
| Pubmed | 1.92e-04 | 568 | 73 | 7 | 37774976 | ||
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 1.92e-04 | 135 | 73 | 4 | 29859926 | |
| Pubmed | Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. | 1.93e-04 | 10 | 73 | 2 | 22421440 | |
| Pubmed | YBX2 FASN UBXN4 DST SUGCT YBX1 TTC16 CIAO3 GRIA2 NCBP1 HNRNPU | 2.01e-04 | 1442 | 73 | 11 | 35575683 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | FASN NSFL1C ZKSCAN1 YBX1 FBXO11 NCBP1 VIRMA CEMIP2 HNRNPU VDAC2 | 2.03e-04 | 1203 | 73 | 10 | 29180619 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SNED1 FASN UBXN4 FBN1 CELSR2 YBX1 MTIF2 EFEMP2 KIF3C HNRNPU VDAC2 | 2.12e-04 | 1451 | 73 | 11 | 30550785 |
| Pubmed | 2.15e-04 | 55 | 73 | 3 | 31640799 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | IVNS1ABP CRTC3 FASN NSFL1C YBX1 NCBP1 API5 WDR26 CNN2 NPLOC4 HNRNPU | 2.17e-04 | 1455 | 73 | 11 | 22863883 |
| Pubmed | 2.18e-04 | 407 | 73 | 6 | 12693553 | ||
| Pubmed | A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. | 2.36e-04 | 11 | 73 | 2 | 17903305 | |
| Pubmed | Do Gametes Woo? Evidence for Their Nonrandom Union at Fertilization. | 2.36e-04 | 11 | 73 | 2 | 28978771 | |
| Pubmed | Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. | 2.36e-04 | 11 | 73 | 2 | 14668353 | |
| Interaction | CSDE1 interactions | 8.57e-06 | 284 | 73 | 8 | int:CSDE1 | |
| Interaction | ZFP36L2 interactions | 1.13e-05 | 211 | 73 | 7 | int:ZFP36L2 | |
| Cytoband | 5p13 | 3.34e-04 | 17 | 73 | 2 | 5p13 | |
| GeneFamily | Y box binding proteins | 1.90e-05 | 3 | 46 | 2 | 106 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 1.32e-04 | 7 | 46 | 2 | 1350 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.10e-04 | 57 | 46 | 3 | 1179 | |
| GeneFamily | Non-clustered protocadherins | 4.11e-04 | 12 | 46 | 2 | 21 | |
| GeneFamily | UBX domain containing | 4.85e-04 | 13 | 46 | 2 | 364 | |
| GeneFamily | Kelch like|BTB domain containing | 5.11e-03 | 42 | 46 | 2 | 617 | |
| GeneFamily | Fibronectin type III domain containing | 7.81e-03 | 160 | 46 | 3 | 555 | |
| GeneFamily | EF-hand domain containing | 1.82e-02 | 219 | 46 | 3 | 863 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_TH1_UP | 1.87e-05 | 197 | 73 | 6 | M5532 | |
| Coexpression | GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP | 2.04e-05 | 200 | 73 | 6 | M5122 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP | 2.04e-05 | 200 | 73 | 6 | M7903 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 2.04e-05 | 200 | 73 | 6 | M6583 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN | 2.04e-05 | 200 | 73 | 6 | M3929 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 4.56e-05 | 25 | 73 | 3 | M47986 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | 7.95e-05 | 504 | 73 | 8 | M2157 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 8.24e-05 | 257 | 73 | 6 | M13867 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 8.18e-10 | 187 | 73 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-09 | 194 | 73 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.14e-09 | 195 | 73 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-09 | 200 | 73 | 8 | c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-09 | 200 | 73 | 8 | 137f8f9d255c66336d4f8b44b2e3f3de721f2bf0 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.39e-09 | 200 | 73 | 8 | 25d3865aa2ced11a5ed40013e83b47d942fdf582 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-08 | 185 | 73 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-08 | 185 | 73 | 7 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-08 | 185 | 73 | 7 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-08 | 186 | 73 | 7 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.47e-08 | 187 | 73 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.57e-08 | 188 | 73 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.86e-08 | 191 | 73 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.97e-08 | 192 | 73 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.97e-08 | 192 | 73 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.07e-08 | 193 | 73 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-08 | 194 | 73 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-08 | 195 | 73 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.42e-08 | 196 | 73 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.54e-08 | 197 | 73 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.54e-08 | 197 | 73 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 3.66e-08 | 198 | 73 | 7 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.66e-08 | 198 | 73 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.79e-08 | 199 | 73 | 7 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.79e-08 | 199 | 73 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.79e-08 | 199 | 73 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.79e-08 | 199 | 73 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.79e-08 | 199 | 73 | 7 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.92e-08 | 200 | 73 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.92e-08 | 200 | 73 | 7 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-08 | 200 | 73 | 7 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.92e-08 | 200 | 73 | 7 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.92e-08 | 200 | 73 | 7 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-08 | 200 | 73 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-08 | 200 | 73 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.92e-08 | 200 | 73 | 7 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-08 | 200 | 73 | 7 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-08 | 200 | 73 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.92e-08 | 200 | 73 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-08 | 200 | 73 | 7 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 3.92e-08 | 200 | 73 | 7 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | 3.92e-08 | 200 | 73 | 7 | dec9ce1bc2571197003596f32e5f742ede72aa79 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-08 | 200 | 73 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-08 | 200 | 73 | 7 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.92e-08 | 200 | 73 | 7 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.92e-08 | 200 | 73 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-07 | 154 | 73 | 6 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-07 | 154 | 73 | 6 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 2.48e-07 | 159 | 73 | 6 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-07 | 168 | 73 | 6 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-07 | 171 | 73 | 6 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-07 | 171 | 73 | 6 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-07 | 171 | 73 | 6 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-07 | 175 | 73 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 4.98e-07 | 179 | 73 | 6 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.03e-07 | 185 | 73 | 6 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 6.03e-07 | 185 | 73 | 6 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-07 | 186 | 73 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.84e-07 | 189 | 73 | 6 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.84e-07 | 189 | 73 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.05e-07 | 190 | 73 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.05e-07 | 190 | 73 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.27e-07 | 191 | 73 | 6 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.27e-07 | 191 | 73 | 6 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-07 | 191 | 73 | 6 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.27e-07 | 191 | 73 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.50e-07 | 192 | 73 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.50e-07 | 192 | 73 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-07 | 192 | 73 | 6 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 7.50e-07 | 192 | 73 | 6 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.50e-07 | 192 | 73 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 7.73e-07 | 193 | 73 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 7.73e-07 | 193 | 73 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.73e-07 | 193 | 73 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.73e-07 | 193 | 73 | 6 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 7.96e-07 | 194 | 73 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 7.96e-07 | 194 | 73 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 7.96e-07 | 194 | 73 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.96e-07 | 194 | 73 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.96e-07 | 194 | 73 | 6 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 7.96e-07 | 194 | 73 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.21e-07 | 195 | 73 | 6 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.21e-07 | 195 | 73 | 6 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 8.21e-07 | 195 | 73 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.21e-07 | 195 | 73 | 6 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.21e-07 | 195 | 73 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.21e-07 | 195 | 73 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 8.21e-07 | 195 | 73 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.21e-07 | 195 | 73 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.21e-07 | 195 | 73 | 6 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.21e-07 | 195 | 73 | 6 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.21e-07 | 195 | 73 | 6 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-07 | 196 | 73 | 6 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.45e-07 | 196 | 73 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.45e-07 | 196 | 73 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.45e-07 | 196 | 73 | 6 | 988a3e0688e0a7ba69774497d3b130631bb26c50 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.71e-07 | 197 | 73 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.71e-07 | 197 | 73 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.71e-07 | 197 | 73 | 6 | 6b6440f1baad5680cf9e13ca3ab72a2c65523d59 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.71e-07 | 197 | 73 | 6 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.28e-06 | 197 | 73 | 7 | 4233_DN | |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; PC3; HT_HG-U133A | 3.39e-06 | 198 | 73 | 7 | 3997_UP | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A | 3.39e-06 | 198 | 73 | 7 | 7313_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.54e-05 | 192 | 73 | 6 | 2450_UP | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; HL60; HT_HG-U133A | 3.97e-05 | 196 | 73 | 6 | 3025_UP | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 3.97e-05 | 196 | 73 | 6 | 3473_UP | |
| Drug | Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; PC3; HT_HG-U133A | 4.09e-05 | 197 | 73 | 6 | 5823_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.09e-05 | 197 | 73 | 6 | 4732_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A | 4.09e-05 | 197 | 73 | 6 | 4277_DN | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; PC3; HT_HG-U133A | 4.21e-05 | 198 | 73 | 6 | 5837_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; HL60; HT_HG-U133A | 4.45e-05 | 200 | 73 | 6 | 3056_UP | |
| Drug | 3-isoxazolol | 6.06e-05 | 4 | 73 | 2 | CID009964065 | |
| Drug | sunifiram | 6.06e-05 | 4 | 73 | 2 | CID004223812 | |
| Drug | 4-(chloromethyl)-3-methoxy-5-methylisoxazole | 6.06e-05 | 4 | 73 | 2 | CID011105661 | |
| Drug | 4-CO | 6.06e-05 | 4 | 73 | 2 | CID000446968 | |
| Drug | AC1L1YEG | 1.01e-04 | 5 | 73 | 2 | CID000063114 | |
| Drug | Chicago acid | 1.01e-04 | 5 | 73 | 2 | CID000065740 | |
| Drug | CHEBI:570577 | 1.01e-04 | 5 | 73 | 2 | CID011334126 | |
| Drug | 1-BCP | 1.01e-04 | 5 | 73 | 2 | CID000001370 | |
| Drug | irampanel | 1.01e-04 | 5 | 73 | 2 | CID003038472 | |
| Drug | beta-N-oxalylaminoalanine | 1.01e-04 | 5 | 73 | 2 | CID000107978 | |
| Drug | LY395153 | 1.01e-04 | 5 | 73 | 2 | CID000656707 | |
| Drug | 5-h PCA | 1.01e-04 | 5 | 73 | 2 | CID000129091 | |
| Disease | refractive error, age at onset, Myopia | 8.57e-06 | 193 | 73 | 6 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | aortic aneurysm (is_implicated_in) | 1.81e-05 | 3 | 73 | 2 | DOID:3627 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 1.81e-05 | 3 | 73 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 3.61e-05 | 4 | 73 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 3.61e-05 | 4 | 73 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | visual epilepsy (implicated_via_orthology) | 8.23e-05 | 34 | 73 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | interleukin 4 measurement | 9.78e-05 | 36 | 73 | 3 | EFO_0008184 | |
| Disease | carbonic anhydrase-related protein 10 measurement | 1.67e-04 | 8 | 73 | 2 | EFO_0020233 | |
| Disease | mitral valve prolapse (is_implicated_in) | 2.15e-04 | 9 | 73 | 2 | DOID:988 (is_implicated_in) | |
| Disease | Abnormality of refraction | 2.56e-04 | 673 | 73 | 8 | HP_0000539 | |
| Disease | gestational age | 3.88e-04 | 138 | 73 | 4 | EFO_0005112 | |
| Disease | cardiomyopathy (is_implicated_in) | 1.00e-03 | 19 | 73 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | pain | 1.44e-03 | 196 | 73 | 4 | EFO_0003843 | |
| Disease | retinal vasculature measurement | 1.77e-03 | 517 | 73 | 6 | EFO_0010554 | |
| Disease | gastroesophageal reflux disease | 2.03e-03 | 101 | 73 | 3 | EFO_0003948 | |
| Disease | ganglion cell inner plexiform layer thickness measurement | 2.19e-03 | 28 | 73 | 2 | EFO_0600005 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYIVVGAGNNQQFAT | 286 | Q9HAC7 | |
| GGFQGILQINDFAYE | 121 | Q9UKF5 | |
| GNQFVYRDGGFAAEQ | 1061 | Q15303 | |
| PIYGRTSGNGFNFND | 2881 | Q7Z407 | |
| FNGNNRGYAFVTFSN | 91 | Q9NQ94 | |
| DGMGRYNVFNFQNVG | 461 | Q14832 | |
| FENRNGTDGLSYNGA | 936 | Q8N139 | |
| NLGNFNYEQRGAFRG | 491 | Q9BZZ5 | |
| GNARGQFYLDAQTGA | 441 | Q9HCU4 | |
| AWFVGRFFQGNYGNA | 441 | O75907 | |
| QRDGYQQNFKRGSGQ | 666 | Q14444 | |
| NLNYGGASNFGLNFL | 331 | Q9Y2Q0 | |
| QNEEYGGARYLGNNQ | 311 | Q8TE56 | |
| VRFIYGGCGGNRNNF | 336 | Q06481 | |
| DYFGQQFDQISNRTG | 341 | P98082 | |
| FRGDTNFYGKQGIQF | 491 | Q02252 | |
| YGQVQVFGFTISQGQ | 146 | Q5SY16 | |
| HRFGGQGNQFSYIQS | 301 | Q5D862 | |
| QSPNGRYQFNFHEGQ | 171 | Q96S86 | |
| GLLNARNYNFGGEFV | 91 | Q09161 | |
| DAINNAAGFGFRGYD | 296 | Q6ZWT7 | |
| TFDGVIYGFNVNAGN | 566 | P46199 | |
| NTIYAVGGFDGNEFL | 606 | Q9Y6Y0 | |
| GDNKYRFFLGNQFGD | 7301 | Q03001 | |
| LQGFNGTVFAYGQTG | 86 | O14782 | |
| QFGGANVSGFQIVDY | 251 | P42262 | |
| QFNDRKQYGSNEGHF | 1191 | Q9HC56 | |
| QGYNNISLGFAFFGT | 141 | Q96LB8 | |
| EFGFQNNGFSVYINR | 36 | Q8TAT6 | |
| NYNQNFRGRGNNRGY | 781 | Q00839 | |
| ANAQRGTYFDGTGFA | 2936 | P24043 | |
| YFSLDVQTQGDGNRF | 166 | Q9P2E7 | |
| GQRFYAGGSERSGQQ | 91 | Q9UNZ2 | |
| IQQRVYEGNAFRGGF | 361 | Q9GZU2 | |
| YEGNAFRGGFRFNST | 366 | Q9GZU2 | |
| VDYFFQRQHGEQLGG | 81 | Q14671 | |
| VYLIGGDNNVQGFRA | 351 | Q53GT1 | |
| AAVNGGVSRYQEAFF | 1511 | Q8N1I0 | |
| NSIFNGNQGGVYIFG | 541 | Q86XK2 | |
| QYGVVVQAFNRAGTG | 1061 | Q8TD84 | |
| GFQYEQFSGGCQDIN | 2636 | P35555 | |
| RQFDGSAFGANYSSQ | 116 | Q6UUV7 | |
| GVFYDANDVGFQRNI | 161 | Q8NCR0 | |
| GNGYNELTGQFRNRV | 141 | P10643 | |
| FVGESRNYGFQGGQN | 831 | Q9UHN6 | |
| GAYNAFQIRAGNSQG | 371 | O95967 | |
| RGNAGQSNYGFANSA | 2026 | P49327 | |
| NAVYTFGLGQFGQLG | 261 | Q92834 | |
| GVFNGYDGNRVTNFV | 66 | Q15750 | |
| NQGYDRVIFTGQFVN | 196 | Q6UWF7 | |
| YVATFLGFGGNAARQ | 321 | Q9Y227 | |
| IAAQAGFNAGDGQRY | 211 | Q8TER0 | |
| DGSYFQINQDGGTRR | 46 | Q9H6Q4 | |
| FKCNGNGNEFYLGNS | 241 | Q8IXR9 | |
| NQSGQVFGLGRQIYD | 256 | Q99439 | |
| FNVRNGYGFINRNDT | 101 | Q9Y2T7 | |
| FNVRNGYGFINRNDT | 66 | P67809 | |
| FDVERNSCNNFIYGG | 151 | O43291 | |
| FQYFDGANGTLRNVS | 46 | Q9NS62 | |
| QFDHFLVQYRNGDGQ | 3086 | P22105 | |
| TRNNFAVGYRTGDFQ | 176 | P45880 | |
| IRGEGFSQANQFNYG | 51 | Q86WI1 | |
| GNNTVRFNPNFYRNG | 171 | Q9H832 | |
| QYPNGSANGFGAVRN | 91 | Q9BZ95 | |
| GLYINRGDCFFQLGN | 366 | Q8NEE8 | |
| RQENYGSAFPQGGEN | 256 | P17029 | |
| FVTGGQRGQFYQCDL | 461 | Q9H7D7 | |
| GFQQQSNFYPGFQGR | 1736 | Q9BXT5 | |
| ALFSQYVVNFGAGDG | 251 | P48553 | |
| QEGYQNQGQGFQSRD | 626 | Q6XPR3 | |
| RQFAAQTVGNTYGNF | 346 | Q92575 | |
| NYNESRGGQSNFNRG | 1736 | Q69YN4 | |
| GYRQQRNRGFGQSNS | 566 | Q9UPU9 | |
| NNGFTSVQGYAFNGT | 186 | P16473 |